Clinical trial
A Clinical Trial Trial of Gemcitabine in Children with Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
NCT02992015 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Trial Trial of Gemcitabine in Children with Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 23, 2016
- Completion date
- March 6, 2024
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.